MECHELEN, BELGIUM--(MARKET WIRE)--Jul 6, 2006 -- Mechelen, Belgium; 6 July 2006 - Galapagos NV (Euronext & LSE: GLPG), an integrated drug discovery company, announced today closure on the acquisition of all the drug discovery operations of Discovery Partners International (DPI) for EUR 4.25 million in cash. With this, the acquired assets of DPI have now become an integral part of Galapagos' service division BioFocus DPI.
